Abstract 17409: Therapeutic Inhibition of RIP1 Improves Metabolic Dysfunction and Inhibits Atherosclerosis in Mouse Models of Cardiometabolic Diseases
Denuja Karunakaran(The University of Queensland), Katey J. Rayner(University of Ottawa), Mary‐Ellen Harper(University of Ottawa), Aldons J. Lusis(ABT Molecular Imaging (United States)), Richard Lee, Hailey Wyatt(Yale University), Joshua W. Kandiah(MACOM (United States)), Calvin Pan(Laboratory of Molecular Genetics), Ruth McPherson(University of Ottawa), Michèle Geoffrion(University of Ottawa), Ella deKemp(University of Ottawa), Ana Mompeón(Northwestern University), Adam W. Turner(University of Virginia), Zachary Lister(MACOM (United States)), My Anh Nguyen(University of Ottawa), Majid Nikpay(University of Ottawa)
Circulation
November 14, 2017
Cited by 0
Related Papers
Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
|Nature Medicine|2013|4.4k
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
|Nature|2010|4k
Multi-omics approaches to disease
|Genome biology|2017|2.7k
CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer
|Nature Immunology|2009|1.5k
MiR-33 Contributes to the Regulation of Cholesterol Homeostasis
|Science|2010|1.3k